STAT3 is also a critical transcriptional regulatory target of EGFR, and its activation regulates DNA damage repair, autophagy, apoptosis, proliferation, angiogenesis, migration, invasion, and immune suppression in lung cancer cells (37–39). The gene discussed is STAT3; the disease is lung carcinoma.